clinical studies of the use of these three drugs , alone or in combination with each other or with anticoagulants , for the treatment of thrombotic disorders associated with valvular heart disease , prosthetic heart valves , cerebral vascular disease ( e.g. , transient ischemic attacks ) , coronary artery diseases ( including myocardial infarction ) , peripheral vascular disease , renal disease and renal allograft rejection are reviewed and evaluated .
C0022658
renal disease
C0022646
renal